Last reviewed · How we verify
Yellow fever vaccine, Bio-Manguinhos
At a glance
| Generic name | Yellow fever vaccine, Bio-Manguinhos |
|---|---|
| Sponsor | Epicentre |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE) (PHASE4)
- Clinical Study of Immunity Duration of Yellow Fever Vaccine in Military
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Yellow fever vaccine, Bio-Manguinhos CI brief — competitive landscape report
- Yellow fever vaccine, Bio-Manguinhos updates RSS · CI watch RSS
- Epicentre portfolio CI